Source: Journal of Pathology and Translational Medicine. Unidade: FMRP
Subjects: TUMOR CARCINOIDE, SISTEMA NERVOSO, BIOMARCADORES, PROGNÓSTICO, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Bruno Henrique Bressan da et al. EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome. Journal of Pathology and Translational Medicine, v. 56, p. 205-211, 2022Tradução . . Disponível em: https://doi.org/10.4132/jptm.2022.04.22. Acesso em: 25 out. 2025.APA
Costa, B. H. B. da, Becker, A. P., Neder, L., Gonçalves, P. G., Oliveira, C. de, Polverini, A. D., et al. (2022). EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome. Journal of Pathology and Translational Medicine, 56, 205-211. doi:10.4132/jptm.2022.04.22NLM
Costa BHB da, Becker AP, Neder L, Gonçalves PG, Oliveira C de, Polverini AD, Clara CA, Teixeira GR, Reis RM, Bidinotto LT. EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome [Internet]. Journal of Pathology and Translational Medicine. 2022 ; 56 205-211.[citado 2025 out. 25 ] Available from: https://doi.org/10.4132/jptm.2022.04.22Vancouver
Costa BHB da, Becker AP, Neder L, Gonçalves PG, Oliveira C de, Polverini AD, Clara CA, Teixeira GR, Reis RM, Bidinotto LT. EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome [Internet]. Journal of Pathology and Translational Medicine. 2022 ; 56 205-211.[citado 2025 out. 25 ] Available from: https://doi.org/10.4132/jptm.2022.04.22
